Clindesse Cream
Product Images NDC 45802-042

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Clindesse (NDC 45802-042). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2s0e6rcc3

FDA Label Image

Aa398rcc3

Aa398rcc3
This is a product description for a vaginal cream containing clindamycin phosphate. It comes in a pre-filled, disposable applicator and provides one complete course of therapy. The product is labeled "PROFESSIONAL NOC 5802 04202" and has a warning not to be sold.*
FDA Label Image

Image 01

Image 01
This is a brief summary of adverse events data for the drug Clindesse compared to placebo. The data presents the number and percentage of individuals who experienced different adverse events. The adverse events mentioned include vaginosis fungal, headache, back pain, constipation, and urinary tract infection. The numbers in the table represent the number of individuals who experienced each adverse event in two separate groups, one of 85 participants and another one of 85 participants, respectively. The table is not very readable due to some unclear characters.*
FDA Label Image

Image 02

FDA Label Image

Image 03

Image 03
The text appears to be a comparison of the outcome of Clindesse treatment vs placebo treatment in a study involving 78 individuals who received Clindesse and 66 who received the placebo. The outcomes are presented as a percentage of cure for therapeutic, clinical, and Nugent Score measures, along with the difference and confidence interval.*
FDA Label Image

Image 04

Image 04
The text describes the results of a study evaluating the effectiveness of a single dose of Clindamycin vaginal cream (Clindesse) for the treatment of a medical condition, based on various cure measures. These measures include therapeutic cure, clinical cure, and Nugent Score cure, and are expressed in percentages for two different treatment groups. Additionally, the table displays differences and confidence intervals for each measure.*
FDA Label Image

Image 05

FDA Label Image

Image 06

FDA Label Image

Image 07

FDA Label Image

Image 08

FDA Label Image

Serialization Template 01

Serialization Template 01
This text provides a template for recording important information about a product, including its serial number, lot number, and expiration date. The information is useful for tracking the product's origins, monitoring its shelf life, and identifying it in case of a faulty or defective batch.*
FDA Label Image

Serialization Template

Serialization Template
This is a template for providing information about a product. It requires the user to insert the product's serial number, lot number, and expiration date. The purpose of this template is likely for tracking purposes, such as inventory management or quality control.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.